Adial Pharmaceuticals (ADIL)
Adial Pharmaceuticals on one page: short interest, daily short volume, fails to deliver, large holders, 13F holders, earnings dates and insider trades. Listed on Nasdaq.
180K
Short interest
settlement 2026-10-15
4.5
Days to cover
+0.2 days vs prior
33.1%
Short share of volume
2026-10-28
203
Fails to deliver
settlement 2026-10-14
Fri 13 Nov
Next earnings
estimated date
$0
Insider flow, 90 days
0 buys, 0 sells
As of 2026-10-28.
Short interest
FINRA, twice a month. The newest 48 settlements in the table, 48 in the chart. JSONAs of 15 October 2026, short interest in ADIL is 179,569 shares, down 30,414 shares over the last month. Over the last 48 readings it ranged from 20,544 shares (15 January 2025) to 3,482,368 shares (31 July 2025). The latest reading sits at the bottom of that range. At the reported average volume of 40K shares a day that is 4.5 days to cover.
Embed this chart.The embed keeps its attribution line.
<iframe src="https://xoomar.com/embed/stocks/adil" width="100%" height="440" style="border:0;max-width:100%" loading="lazy" title="XOOMAR chart"></iframe>
| Settlement | Shares short | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|
| 2026-10-15 | 179,569 | -2.0% | 40,203 | 4.47 |
| 2026-09-30 | 183,323 | -12.7% | 42,787 | 4.28 |
| 2026-09-15 | 209,983 | -14.2% | 50,889 | 4.13 |
| 2026-08-31 | 244,723 | +5.6% | 79,531 | 3.08 |
| 2026-08-14 | 231,709 | -0.8% | 85,105 | 2.72 |
| 2026-07-31 | 233,654 | -4.1% | 42,335 | 5.52 |
| 2026-07-15 | 243,624 | +5.5% | 45,584 | 5.34 |
| 2026-06-30 | 230,979 | -33.5% | 127,279 | 1.81 |
| 2026-06-15 | 347,148 | +634.0% | 1,988,864 | 1.00 |
| 2026-05-29 | 47,293 | -7.3% | 350,070 | 1.00 |
| 2026-05-15 | 51,033 | -25.6% | 97,289 | 1.00 |
| 2026-04-30 | 68,595 | +40.0% | 100,469 | 1.00 |
| 2026-04-15 | 49,013 | -49.4% | 89,800 | 1.00 |
| 2026-03-31 | 96,887 | +21.7% | 73,885 | 1.31 |
| 2026-03-13 | 79,609 | +185.7% | 246,997 | 1.00 |
| 2026-02-27 | 27,868 | -17.2% | 52,717 | 1.00 |
| 2026-02-13 | 33,643 | -87.7% | 78,805 | 1.00 |
| 2026-01-30 | 273,317 | -5.7% | 279,307 | 1.00 |
| 2026-01-15 | 289,881 | -24.9% | 346,754 | 1.00 |
| 2025-12-31 | 385,797 | -5.3% | 373,111 | 1.03 |
| 2025-12-15 | 407,422 | -31.2% | 240,762 | 1.69 |
| 2025-11-28 | 592,267 | +41.2% | 500,963 | 1.18 |
| 2025-11-14 | 419,384 | -54.3% | 280,998 | 1.49 |
| 2025-10-31 | 917,955 | +104.9% | 548,765 | 1.67 |
| 2025-10-15 | 448,070 | -59.7% | 895,984 | 1.00 |
| 2025-09-30 | 1,111,838 | -9.6% | 731,068 | 1.52 |
| 2025-09-15 | 1,229,455 | -14.0% | 568,803 | 2.16 |
| 2025-08-29 | 1,430,247 | -22.2% | 528,407 | 2.71 |
| 2025-08-15 | 1,839,059 | -47.2% | 1,072,877 | 1.71 |
| 2025-07-31 | 3,482,368 | +920.6% | 6,168,507 | 1.00 |
| 2025-07-15 | 341,215 | -63.5% | 3,185,824 | 1.00 |
| 2025-06-30 | 933,683 | +90.5% | 42,759,689 | 1.00 |
| 2025-06-13 | 490,072 | +264.8% | 1,797,040 | 1.00 |
| 2025-05-30 | 134,334 | -63.0% | 150,851 | 1.00 |
| 2025-05-15 | 362,866 | +159.5% | 3,026,614 | 1.00 |
| 2025-04-30 | 139,831 | -35.6% | 27,861 | 5.02 |
| 2025-04-15 | 217,057 | -48.0% | 54,483 | 3.98 |
| 2025-03-31 | 417,407 | -24.0% | 75,151 | 5.55 |
| 2025-03-14 | 549,373 | -19.8% | 88,148 | 6.23 |
| 2025-02-28 | 685,273 | +609.9% | 4,944,428 | 1.00 |
| 2025-02-14 | 96,525 | +59.3% | 81,125 | 1.19 |
| 2025-01-31 | 60,591 | +194.9% | 196,444 | 1.00 |
| 2025-01-15 | 20,544 | -8.9% | 67,530 | 1.00 |
| 2024-12-31 | 22,546 | -60.9% | 106,759 | 1.00 |
| 2024-12-13 | 57,622 | +16.4% | 303,730 | 1.00 |
| 2024-11-29 | 49,486 | -71.7% | 127,449 | 1.00 |
| 2024-11-15 | 175,004 | +121.9% | 267,717 | 1.00 |
| 2024-10-31 | 78,882 | +54.1% | 181,398 | 1.00 |
Daily short volume
FINRA Reg SHO, the last 30 sessions. JSONAs of 28 October 2026, the short share of ADIL volume is 33.1%, down 31.3 points over the last five sessions. Over the last 30 readings it ranged from 12.2% (12 October 2026) to 82.0% (14 October 2026). The latest reading is 11.3 points below the 30-session average of 44.5%, on 35K shares reported.
| Date | Short volume | Total volume | Short share | Exempt |
|---|---|---|---|---|
| 2026-10-28 | 12K | 35K | 33.1% | 0 |
| 2026-10-27 | 492 | 1K | 35.2% | 0 |
| 2026-10-26 | 930 | 4K | 24.1% | 0 |
| 2026-10-23 | 6K | 9K | 67.3% | 0 |
| 2026-10-22 | 384 | 1K | 36.5% | 0 |
| 2026-10-21 | 7K | 11K | 64.4% | 0 |
| 2026-10-20 | 608 | 3K | 23.0% | 0 |
| 2026-10-19 | 1K | 3K | 33.5% | 0 |
| 2026-10-16 | 7K | 15K | 46.5% | 0 |
| 2026-10-15 | 3K | 4K | 71.8% | 0 |
| 2026-10-14 | 14K | 17K | 82.0% | 0 |
| 2026-10-13 | 7K | 9K | 77.3% | 68 |
| 2026-10-12 | 2K | 16K | 12.2% | 143 |
| 2026-10-09 | 237 | 743 | 31.9% | 0 |
| 2026-10-08 | 1K | 3K | 37.6% | 0 |
| 2026-10-07 | 445 | 839 | 53.0% | 0 |
| 2026-10-06 | 2K | 3K | 57.2% | 0 |
| 2026-10-05 | 8K | 13K | 63.9% | 0 |
| 2026-10-02 | 3K | 8K | 38.0% | 0 |
| 2026-10-01 | 2K | 7K | 26.6% | 0 |
| 2026-09-30 | 1K | 4K | 28.9% | 0 |
| 2026-09-29 | 6K | 9K | 73.4% | 0 |
| 2026-09-28 | 16K | 27K | 60.1% | 0 |
| 2026-09-25 | 4K | 20K | 20.0% | 839 |
| 2026-09-24 | 3K | 8K | 30.6% | 62 |
| 2026-09-23 | 15K | 23K | 66.7% | 411 |
| 2026-09-22 | 5K | 15K | 33.3% | 437 |
| 2026-09-21 | 3K | 24K | 12.8% | 453 |
| 2026-09-18 | 11K | 21K | 52.7% | 252 |
| 2026-09-17 | 4K | 11K | 39.9% | 0 |
Fails to deliver
SEC, the last 30 settlement dates with a fail. JSONAs of 14 October 2026, the fails-to-deliver balance in ADIL is 203 shares, down 17 shares over the last settlement date. Over the last 30 readings it ranged from 195 shares (27 August 2026) to 17,855 shares (14 August 2026). The latest reading sits at the bottom of that range.
| Settlement | Shares failed | Price | Value |
|---|---|---|---|
| 2026-10-14 | 203 | $3.29 | $668 |
| 2026-10-06 | 220 | $4.35 | $957 |
| 2026-10-01 | 2,395 | $4.01 | $10K |
| 2026-09-24 | 667 | $4.04 | $3K |
| 2026-09-21 | 1,885 | $4.86 | $9K |
| 2026-09-16 | 7,230 | $5.00 | $36K |
| 2026-09-15 | 7,112 | $5.00 | $36K |
| 2026-09-14 | 10,338 | $4.90 | $51K |
| 2026-09-11 | 4,772 | $6.00 | $29K |
| 2026-09-10 | 3,176 | $5.93 | $19K |
| 2026-09-09 | 3,642 | $6.65 | $24K |
| 2026-09-08 | 6,191 | $7.12 | $44K |
| 2026-09-04 | 5,068 | $6.66 | $34K |
| 2026-09-03 | 3,258 | $6.32 | $21K |
| 2026-09-02 | 8,458 | $5.95 | $50K |
| 2026-09-01 | 2,855 | $5.75 | $16K |
| 2026-08-31 | 6,373 | $5.60 | $36K |
| 2026-08-28 | 5,477 | $5.69 | $31K |
| 2026-08-27 | 195 | $5.94 | $1K |
| 2026-08-26 | 982 | $5.82 | $6K |
| 2026-08-25 | 767 | $5.40 | $4K |
| 2026-08-24 | 3,544 | $6.22 | $22K |
| 2026-08-21 | 5,373 | $5.90 | $32K |
| 2026-08-19 | 3,108 | $5.45 | $17K |
| 2026-08-18 | 11,884 | $4.99 | $59K |
| 2026-08-17 | 9,921 | $3.98 | $39K |
| 2026-08-14 | 17,855 | $4.39 | $78K |
| 2026-08-13 | 14,070 | $4.31 | $61K |
| 2026-08-12 | 11,261 | $4.31 | $49K |
| 2026-08-11 | 16,373 | $4.21 | $69K |
Insider trades
SEC Form 4, newest first. JSONNo open-market insider trades were reported for ADIL in the last 90 days. The most recent filings are listed below. Latest filing: Davidson Matt (President and CEO) on 2026-10-28.
| Date | Insider | Title | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|---|
| 2026-10-28 | Davidson Matt | President and CEO | Grant | 232K | $0.00 | $0 | 294K |
| 2026-07-16 | Coastlands Capital LP | 10% owner | Buy | 1K | $2.75 | $3K | 388K |
| 2026-07-14 | Coastlands Capital LP | 10% owner | Buy | 2K | $2.65 | $5K | 387K |
| 2026-07-10 | Coastlands Capital LP | 10% owner | Buy | 2K | $2.70 | $5K | 385K |
| 2026-07-09 | Coastlands Capital LP | 10% owner | Buy | 10K | $2.79 | $28K | 383K |
| 2026-06-29 | Coastlands Capital LP | 10% owner | Buy | 25K | $2.60 | $65K | 373K |
| 2026-06-12 | Davidson Matt | Chief Development Officer | Grant | 232K | $0.00 | $0 | 297K |
| 2026-06-11 | Davidson Matt | Chief Development Officer | Grant | 62K | price not stated in the filing | not stated | 62K |
| 2026-06-11 | Davidson Matt | Chief Development Officer | Grant | 2K | price not stated in the filing | not stated | 2K |
| 2026-06-11 | Davidson Matt | Chief Development Officer | Grant | 101 | price not stated in the filing | not stated | 2K |
| 2026-06-11 | Davidson Matt | Chief Development Officer | Grant | 3K | price not stated in the filing | not stated | 3K |
| 2026-04-07 | Goodman Tony | Chief Operating Officer | Grant | 27K | $0.00 | $0 | 27K |
| 2026-04-07 | Shah Vinay | Chief Financial Officer | Grant | 17K | $0.00 | $0 | 17K |
| 2026-04-07 | Schuyler Kevin | Director | Grant | 9K | $0.00 | $0 | 9K |
| 2026-04-07 | Gilliland Robertson H. | Director | Grant | 9K | $0.00 | $0 | 9K |
| 2026-04-07 | Claiborne Cary J | Chief Executive Officer | Grant | 38K | $0.00 | $0 | 40K |
| 2023-09-29 | Schuyler Kevin | Director | Buy | 700 | $2.74 | $2K | 700 |
| 2023-05-23 | Claiborne Cary J | Chief Executive Officer | Grant | 420K | $0.00 | $0 | 1.5M |
| 2023-05-23 | Stilley William B. III | Director | Grant | 241K | $0.00 | $0 | 1.3M |
| 2023-05-23 | Truluck Joseph | Chief Financial Officer | Grant | 158K | $0.00 | $0 | 265K |
| 2022-12-30 | Stilley William B. III | Director | Returned to company | 167K | $0.00 | $0 | 1.0M |
| 2022-09-20 | Claiborne Cary J | Chief Executive Officer | Grant | 75K | $0.42 | $32K | 1.1M |
| 2022-09-19 | Claiborne Cary J | Chief Executive Officer | Grant | 25K | $0.43 | $11K | 1.0M |
| 2022-08-18 | Claiborne Cary J | Chief Executive Officer | Grant | 1.0M | $0.00 | $0 | 1.0M |
| 2022-02-23 | Stilley William B. III | Chief Executive Officer | Grant | 250K | $0.00 | $0 | 1.2M |
| 2021-12-30 | Newman James W. Jr. | Director | Buy | 10K | $2.71 | $27K | 35K |
| 2021-12-30 | Newman James W. Jr. | Director | Buy | 5K | $2.72 | $14K | 50K |
| 2021-12-30 | Newman James W. Jr. | Director | Buy | 10K | $2.66 | $27K | 20K |
| 2021-12-23 | Schuyler Kevin | Director,TenPercentOwner | Gift | 313K | $0.00 | $0 | 0 |
| 2021-11-30 | Stilley William B. III | Chief Executive Officer | Buy | 11K | $2.75 | $29K | 938K |
| 2021-11-29 | Stilley William B. III | Chief Executive Officer | Buy | 10K | $2.59 | $26K | 927K |
| 2021-11-26 | Newman James W. Jr. | Director | Buy | 10K | $2.85 | $29K | 34K |
| 2021-10-04 | Johnson Bankole A. | Chief Medical Officer | Sell | 200K | $1.00 | $200K | 148K |
| 2021-04-06 | Johnson Bankole A. | Chief Medical Officer | Sell | 150K | $2.50 | $375K | 548K |
| 2021-01-26 | Newman James W. Jr. | Director | Grant | 1K | price not stated in the filing | not stated | 14K |
| 2021-01-26 | Newman James W. Jr. | Director | Grant | 3K | price not stated in the filing | not stated | 153K |
| 2021-01-26 | Stilley William B. III | Chief Executive Officer | Grant | 201K | price not stated in the filing | not stated | 917K |
| 2020-08-20 | Johnson Bankole A. | Chief Medical Officer | Sell | 350K | $1.21 | $424K | 1K |
| 2020-03-27 | Newman James W. Jr. | Director | Buy | 5K | $1.42 | $7K | 15K |
| 2020-03-27 | Newman James W. Jr. | Director | Buy | 5K | $1.35 | $6K | 15K |
| 2020-03-27 | Newman James W. Jr. | Director | Buy | 10K | $1.34 | $13K | 13K |
| 2020-03-26 | Stilley William B. III | Chief Executive Officer | Buy | 13K | $1.47 | $19K | 716K |
| 2020-03-25 | Stilley William B. III | Chief Executive Officer | Buy | 12K | $1.13 | $14K | 703K |
| 2020-03-03 | Truluck Joseph | Chief Financial Officer | Grant | 27K | $0.00 | $0 | 108K |
| 2020-03-03 | Stilley William B. III | Chief Executive Officer | Grant | 54K | $0.00 | $0 | 691K |
| 2018-07-31 | Schuyler Kevin | Director | Buy | 90K | price not stated in the filing | not stated | 313K |
| 2018-07-31 | Schuyler Kevin | Director | Other transaction | 90K | price not stated in the filing | not stated | 223K |
| 2018-07-31 | Schuyler Kevin | Director | Other transaction | 144K | price not stated in the filing | not stated | 144K |
Form 4 filings are due within two business days of the trade. Insiders sell for many reasons that say nothing about the company; open-market buys are rarer.
Large holders (13D and 13G)
One row per reporting person with its latest filing, newest first. JSON5 holders report 5% or more of ADIL in their latest filing, all on Schedule 13G (passive). The largest reported stake is Coastlands Capital LP at 14.2% of the class (373,322 shares), filed 2026-07-01 for an event on 2026-06-24.
| Filed | Form | Holder | Shares | Of class | Event |
|---|---|---|---|---|---|
| 2026-07-01 | 13G/Ano. 1 | Coastlands Capital LPinvestment adviser, partnership | 373K | 14.2% | 2026-06-24 |
| 2026-07-01 | 13G/Ano. 1 | Coastlands Capital Partners LPpartnership | 373K | 14.2% | 2026-06-24 |
| 2026-07-01 | 13G/Ano. 1 | Coastlands Capital GP LLCother entity | 373K | 14.2% | 2026-06-24 |
| 2026-07-01 | 13G/Ano. 1 | Coastlands Capital LLCparent holding company, other entity | 373K | 14.2% | 2026-06-24 |
| 2026-07-01 | 13G/Ano. 1 | Matthew D. Perryparent holding company, individual | 373K | 14.2% | 2026-06-24 |
| 2026-05-15 | 13G/Ano. 1 | Armistice Capital, LLCinvestment adviser, other entity | 274K | 5.0% | 2026-03-31 |
| 2026-05-15 | 13G/Ano. 1 | Steven Boydparent holding company, individual | 274K | 5.0% | 2026-03-31 |
13F holders
Tracked managers holding ADIL at their latest 13F. JSON1 of the 30 tracked managers held ADIL at their latest 13F, $76K in total at quarter-end prices. Citadel Advisors is the largest at $76K (0.0% of its portfolio) as of 2026-06-30. Over the prior quarter 1 added shares and 0 cut.
| Fund | Quarter | Shares | Value | Of portfolio | Change in shares |
|---|---|---|---|---|---|
| Citadel Advisors | 2026-06-30 | 30K | $76K | 0.00% | new |
Only the 30 tracked managers on the funds hub; a 13F reports long positions in US listed stock at quarter end, 45 days late, and says nothing about shorts or positions sold since.
What this page is
Adial Pharmaceuticals in the regulatory record
Regulators publish company data in separate files that never sit next to each other: FINRA's twice-monthly short interest, its daily short sale volume, the SEC's fails-to-deliver counts, and each insider's Form 4. A company page puts those series for one ticker on one URL, with planned sales, large holders, 13F holders and financials beside them, so the short position, the daily flow, the settlement fails and what insiders are doing can be read together.
Each section has its own history table, a one-line summary of the latest figures and its own JSON and CSV links, and says when its source last updated.
This page follows Adial Pharmaceuticals (ADIL), SEC CIK 1513525, listed on Nasdaq. The cross-market tables live on the short interest and insider transactions hubs.
Source and updates
- Short interest
- FINRA consolidated short interestSource: FINRA.Twice a month, about eight business days after settlement. Latest 2026-10-15.JSON and CSV
- Daily short volume
- FINRA Reg SHO daily filesSource: FINRA.Every trading day, the morning after FINRA posts it. Latest 2026-10-28.JSON and CSV
- Fails to deliver
- SEC fails-to-deliver dataSource: SEC.Twice a month, a few weeks after the half month ends. Latest 2026-10-14.JSON and CSV
- Large holders
- SEC EDGAR Schedule 13D and 13GSource: SEC.New filings appear shortly after the SEC posts them. A 13D is due within five business days of crossing 5%; a 13G follows the passive schedule. Latest 2026-07-01.JSON and CSV
- 13F holders
- SEC EDGAR Form 13F-HRSource: SEC.Quarterly, filed within 45 days of quarter end; 30 tracked managers. Latest 2026-06-30.JSON and CSV
- Earnings dates
- SEC EDGAR 8-K filings (Item 2.02)Source: SEC.Twice a day. Reported dates come from the company's 8-K filings; the next date is marked as an estimate until the 8-K arrives. Latest 2026-08-17.JSON and CSV
- Insider trades
- SEC EDGAR Form 4Source: SEC.New filings appear shortly after the SEC posts them; they're due two business days after the trade. Latest 2026-10-28.JSON and CSV
- Company record
- EDGAR filing index for CIK 1513525Ticker, name and exchange from the SEC's company list, refreshed weekly.
- Rate limits
- 10 requests a minute without a key, 30 with a free key from a free account.
How to read it
- Read the position against the flow: rising short interest with a high daily short share is new shorting; rising short interest with a normal short share is old shorts holding on.
- Insider buys next to a large short position are rare and stand out; insider sells next to one are common and mean little.
- Fails to deliver matter relative to the float, not in absolute shares; a million failed shares in a mega cap is noise.
Analysis of what the data shows, not advice. XOOMAR does not recommend buying, selling or holding anything.
Other company pages
- STESTERIS
- STLDSteel Dynamics
- STRCStrategy
- STRLSterling Infrastructure
- STTState Street
- STXSeagate Technology Holdings
- STZConstellation Brands
- SUISun Communities
- SUNBSunbelt Rentals Holdings
- SWSmurfit Westrock
- SWKStanley Black & Decker
- SWKSSkyworks Solutions
- SXTCChina SXT Pharmaceuticals
- SYFSynchrony Financial
- SYKStryker
- SYNASynaptics
- SYRESpyre Therapeutics
- SYYSysco
- TAT&T
- TAPMolson Coors
- TCOMTrip.com Group
- TDToronto-Dominion Bank
- TDGTransDigm Group
- TDYTeledyne Technologies
Datasets
Frequently Asked Questions
How much of ADIL is sold short?
What is ADIL's daily short volume?
Does ADIL have fails to deliver?
Are ADIL insiders buying or selling?
Who owns 5% or more of ADIL?
Which tracked 13F managers own ADIL?
Data on this page is provided for informational purposes only and is not financial advice. See our editorial policy.